Patents by Inventor Sam CLARK

Sam CLARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N,N-dimethyltryptamine and related psychedelics and uses thereof
    Patent number: 12780784
    Abstract: Described herein are compounds that are derivatives of DMT or 5-MeO-DMT and can be metabolically converted to N,N-dimethyltryptamine or analogs thereof upon administration to a subject. In certain embodiments, the compounds described herein are useful for the treatment of conditions associated with a neurological disease.
    Type: Grant
    Filed: March 3, 2026
    Date of Patent: November 3, 2026
    Assignee: Terran Biosciences Inc.
    Inventors: Sam Clark, Matthew Alexander James Duncton
  • N,N-DIMETHYLTRYPTAMINE AND RELATED PSYCHEDELICS AND USES THEREOF
    Publication number: 20260193183
    Abstract: Described herein are compounds that are derivatives of DMT or 5-MeO-DMT and can be metabolically converted to N,N-dimethyltryptamine or analogs thereof upon administration to a subject. In certain embodiments, the compounds described herein are useful for the treatment of conditions associated with a neurological disease.
    Type: Application
    Filed: March 3, 2026
    Publication date: July 9, 2026
    Inventors: Sam CLARK, Matthew Alexander James DUNCTON
  • PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF
    Publication number: 20250011344
    Abstract: Described herein are compounds that are derivatives (e.g., prodrugs) of psilocin. Also described herein are uses of the compounds provided herein for treating or preventing a disease, disorder, or condition in which an increased level of psilocin is beneficial.
    Type: Application
    Filed: August 19, 2022
    Publication date: January 9, 2025
    Inventors: Sam CLARK, Matthew Alexander James DUNCTON
  • 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND RELATED PSYCHEDELICS AND USES THEREOF
    Publication number: 20240317724
    Abstract: Described herein are compounds that are derivatives (e.g., prodrugs) of 3,4-Methylenedioxymethamphetamine (MDMA). Also described herein are uses of the compounds provided herein for treating or preventing a disease, disorder, or condition in which an increased level of MDMA is beneficial.
    Type: Application
    Filed: July 7, 2022
    Publication date: September 26, 2024
    Inventors: Sam CLARK, Matthew Alexander James DUNCTON
  • DEUTERATED ANALOGS AND DERIVATIVES OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE AND USES THEREOF
    Publication number: 20240294460
    Abstract: Provided herein are deuterated analogs of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and related compounds and their uses for the treatment of conditions associated with a neurological disease.
    Type: Application
    Filed: August 19, 2022
    Publication date: September 5, 2024
    Inventors: Sam CLARK, Matthew Alexander James DUNCTON
  • METHODS AND COMPOSITIONS RELATING TO PSYCHEDELICS AND SEROTONIN RECEPTOR MODULATORS
    Publication number: 20240197681
    Abstract: Provided herein are compositions relating to psychedelics and serotonin receptor modulators. Further provided herein are methods of treating a disease or disorder (e.g., depression or diseases or disorders related to depression) comprising administering psychedelics and serotonin receptor modulators.
    Type: Application
    Filed: April 1, 2022
    Publication date: June 20, 2024
    Inventors: Sam CLARK, Scott THOMPSON
  • N,N-DIMETHYLTRYPTAMINE AND RELATED PSYCHEDELICS AND USES THEREOF
    Publication number: 20240116870
    Abstract: Described herein are compounds that are derivatives of DMT or 5-MeO-DMT and can be metabolically converted to N,N-dimethyltryptamine or analogs thereof upon administration to a subject. In certain embodiments, the compounds described herein are useful for the treatment of conditions associated with a neurological disease.
    Type: Application
    Filed: October 10, 2023
    Publication date: April 11, 2024
    Inventors: Matthew Alexander James DUNCTON, Sam CLARK
  • N,N-dimethyltryptamine and related psychedelics and uses thereof
    Patent number: 11866408
    Abstract: Described herein are compounds that are derivatives of DMT or 5-MeO-DMT and can be metabolically converted to N,N-dimethyltryptamine or analogs thereof upon administration to a subject. In certain embodiments, the compounds described herein are useful for the treatment of conditions associated with a neurological disease.
    Type: Grant
    Filed: February 23, 2023
    Date of Patent: January 9, 2024
    Assignee: TERRAN BIOSCIENCES INC.
    Inventors: Matthew Alexander James Duncton, Sam Clark
  • METHODS AND COMPOSITIONS RELATING TO CONTROLLING PSYCHEDELIC EFFECTS WITH SEROTONIN RECEPTOR MODULATORS
    Publication number: 20240000795
    Abstract: Provided herein are compositions relating to psychedelics and serotonin receptor modulators. Further provided herein are methods of suppressing or halting hallucinogenic effects of a psychedelic and methods of treating a disease or disorder (e.g., depression or diseases or disorders related to depression) comprising administering psychedelics and serotonin receptor modulators.
    Type: Application
    Filed: September 15, 2022
    Publication date: January 4, 2024
    Inventor: Sam CLARK
  • N,N-DIMETHYLTRYPTAMINE AND RELATED PSYCHEDELICS AND USES THEREOF
    Publication number: 20230212119
    Abstract: Described herein are compounds that are derivatives of DMT or 5-MeO-DMT and can be metabolically converted to N,N-dimethyltryptamine or analogs thereof upon administration to a subject. In certain embodiments, the compounds described herein are useful for the treatment of conditions associated with a neurological disease.
    Type: Application
    Filed: February 23, 2023
    Publication date: July 6, 2023
    Inventors: Matthew Alexander James DUNCTON, Sam CLARK